Skip to search.
 TSX Up 0.71% TSX Ventures Up 1.85%

CTI BioPharma Corp. (CTIC)

-NasdaqCM
1.60 Up 0.03(1.91%) Aug 28, 4:00PM EDT
Add to Portfolio
Prev Close:1.57
Open:1.60
Bid:1.58 x 2700
Ask:1.82 x 2000
1y Target Est:5.50
Beta:1.10441
Earnings Date:Oct 27 - Nov 2 (Est.)
Day's Range:1.55 - 1.61
52wk Range:1.50 - 2.94
Volume:920,918
Avg Vol (3m):2,959,710
Market Cap:289.05M
P/E (ttm):N/A
EPS (ttm):-0.61
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
CTICUp 1.91%289.05M
BMYDown 0.35%101.07B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4.50
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.44
Quarterly EPS Est (Sep-15) :-0.09
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback